venlafaxine hydrochloride 75 mg

1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: • major depressive disorder (MDD) [see Clinical Studies ( 14.1 )] • Generalized Anxiety Disorder (GAD) [see Clinical Studies ( 14.2 )] • Social Anxiety Disorder (SAD) [see Clinical Studies ( 14.3 )] • Panic Disorder (PD) [see Clinical Studies ( 14.4 )] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: • major depressive disorder (MDD) ( 1 ) • Generalized Anxiety Disorder (GAD) ( 1 ) • Social Anxiety Disorder (SAD) ( 1 ) • Panic Disorder (PD) ( 1 )

preferred pharmaceuticals, inc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] off label use` `[3] drug ineffective` `[4] diarrhoea` `[5] nausea` `[6] dyspnoea` `[7] pyrexia` `[8] dizziness` `[9] death` `[10] headache`

1 year ago

CAPSULE PINK V 10

16 HOW SUPPLIED/STORAGE AND HANDLING

VENLAFAXINE HYDROCHLORIDE extended-release capsules USP are available as follows: •

VENLAFAXINE HYDROCHLORIDE extended-release capsules USP, 75 mg are white to off white colored, round to oval shaped pellets filled in size '1' hard Gelatin capsules with peach opaque cap imprinted with 'V' in black color, white opaque body imprinted with '10' in black color. Bottle of 30 capsules NDC 68788-8068-3 Bottle of 60 capsules NDC 68788-8068-6 Bottle of 90 capsules NDC 68788-8068-9 Store at controlled room temperature, 20° to 25°C (68° to 77°F). [see USP Controlled Room Temperature]

More pills like CAPSULE V 10

Related Pills

venlafaxine hydrochloride capsule extended release 75 mg

camber pharmaceuticals, inc.